Vertex Historical Cash Flow
| VRTX Stock | USD 433.76 5.17 1.21% |
Analysis of Vertex Pharmaceuticals cash flow over time is an excellent tool to project Vertex Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 3.4 B or Begin Period Cash Flow of 11 B as it is a great indicator of Vertex Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Vertex Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Vertex Pharmaceuticals is a good buy for the upcoming year.
Vertex |
About Vertex Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Vertex balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Vertex's non-liquid assets can be easily converted into cash.
Vertex Pharmaceuticals Cash Flow Chart
Vertex Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Vertex Pharmaceuticals Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Vertex Pharmaceuticals' Cash And Cash Equivalents Changes is fairly stable compared to the past year. Change To Operating Activities is likely to rise to about 863.4 M in 2024, despite the fact that Change In Cash is likely to grow to (132.7 M). Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Vertex Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Vertex Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Vertex Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Vertex Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.At this time, Vertex Pharmaceuticals' Cash And Cash Equivalents Changes is fairly stable compared to the past year. Change To Operating Activities is likely to rise to about 863.4 M in 2024, despite the fact that Change In Cash is likely to grow to (132.7 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 235M | 204.7M | 258.4M | 271.3M | Depreciation | 125.6M | 148.3M | 181.3M | 190.4M |
Vertex Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Vertex Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vertex Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 462.4M | 2.9B | 811.2M | 3.7B | (139.7M) | (132.7M) | |
| Free Cash Flow | 1.5B | 3.0B | 2.4B | 3.9B | 3.3B | 3.4B | |
| Change In Working Capital | (66.1M) | (54.5M) | (105.2M) | 340.8M | (265.7M) | (252.4M) | |
| Begin Period Cash Flow | 2.7B | 3.1B | 6.0B | 6.8B | 10.5B | 11.0B | |
| Other Cashflows From Financing Activities | 24.8M | 276.4M | 130.3M | 3.5M | (224.3M) | (213.1M) | |
| Depreciation | 106.9M | 109.5M | 125.6M | 148.3M | 181.3M | 190.4M | |
| Capital Expenditures | 75.5M | 259.8M | 235M | 204.7M | 258.4M | 271.3M | |
| Total Cash From Operating Activities | 1.6B | 3.3B | 2.6B | 4.1B | 3.5B | 3.7B | |
| Net Income | 1.2B | 2.7B | 2.3B | 3.3B | 3.6B | 3.8B | |
| Total Cash From Financing Activities | 126.8M | (505.3M) | (1.5B) | (67.7M) | (562.2M) | (534.1M) | |
| End Period Cash Flow | 3.1B | 6.0B | 6.8B | 10.5B | 10.4B | 10.9B | |
| Other Non Cash Items | (176.2M) | (220.0M) | (5.8M) | 103.4M | (42.6M) | (40.5M) | |
| Change To Liabilities | 188.1M | 598.6M | 354.1M | 1.2B | 1.3B | 1.4B | |
| Change To Account Receivables | (225.6M) | (223.4M) | (274.7M) | (358.6M) | (84.1M) | (88.3M) | |
| Stock Based Compensation | 360.5M | 429.5M | 441.4M | 491.3M | 581.2M | 610.3M | |
| Other Cashflows From Investing Activities | (1.2B) | (19.3M) | (77M) | (343.7M) | (309.3M) | (293.9M) | |
| Change To Inventory | (64.0M) | (132.0M) | (92.8M) | (136.4M) | (322.9M) | (306.8M) | |
| Total Cashflows From Investing Activities | (1.2B) | 99.4M | (340.9M) | (321.1M) | (289.0M) | (274.5M) | |
| Sale Purchase Of Stock | (192.0M) | (739.4M) | (1.6B) | (172M) | (427.6M) | (406.2M) | |
| Dividends Paid | 20.8M | 10.0M | 264.9M | 102M | 117.3M | 123.2M | |
| Investments | 33.7M | 378.5M | (28.9M) | 227.3M | (2.1B) | (2.0B) | |
| Change Receivables | (225.6M) | (223.4M) | (274.7M) | (358.6M) | (322.7M) | (306.6M) | |
| Net Borrowings | (35.0M) | (29.0M) | (24.4M) | (85.5M) | (77.0M) | (73.1M) | |
| Cash And Cash Equivalents Changes | 460.8M | 2.8B | 824.6M | 3.7B | 4.3B | 4.5B | |
| Cash Flows Other Operating | 5.2M | (332.2M) | (263.5M) | (453.2M) | (407.9M) | (387.5M) | |
| Change To Netincome | 381.9M | 521.4M | 452.7M | 445.6M | 512.4M | 437.4M | |
| Change To Operating Activities | 246.3M | 249.7M | 230.4M | 715M | 822.3M | 863.4M |
Vertex Pharmaceuticals Investors Sentiment
The influence of Vertex Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Vertex. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Vertex Pharmaceuticals' public news can be used to forecast risks associated with an investment in Vertex. The trend in average sentiment can be used to explain how an investor holding Vertex can time the market purely based on public headlines and social activities around Vertex Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vertex Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vertex Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Vertex Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Vertex Pharmaceuticals.
Vertex Pharmaceuticals Implied Volatility | 39.58 |
Vertex Pharmaceuticals' implied volatility exposes the market's sentiment of Vertex Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vertex Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vertex Pharmaceuticals stock will not fluctuate a lot when Vertex Pharmaceuticals' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vertex Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vertex Pharmaceuticals' short interest history, or implied volatility extrapolated from Vertex Pharmaceuticals options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Vertex Stock analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.565 | Earnings Share 15.39 | Revenue Per Share 39.492 | Quarterly Revenue Growth 0.133 | Return On Assets 0.1282 |
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.